Session handouts and meetings archive

Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation

CME & session evaluation archive

Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

DermWorld: Your go-to practice, policy, and care resource

About 260 of you responded to the survey. Here’s what you said: ... Credibility of content, quality of writing = 93% excellent or good ... Visual appeal (cover, overall, art) = 89% excellent or good ... DermWorld content is relevant to my practice = 84% strongly agree or agree ...

Ensuring effectiveness, safety of new skin therapies

A dermatologist leads an FDA advisory committee’s innovation and safety review for new therapies. ... Dr. Katz's story ... Kenneth Katz, MD, MSc, MSCE, FAAD, physician ... New dermatologic treatments can bring great promise to the more than 84 million people in the United States living with skin disease. Such

Academy publications continue to top the charts!

We are your go-to source for navigating practice, policy, and patient care Last year, we asked hundreds of members what they thought about the Academy’s flagship publication, DermWorld, and the results are in. Here are the highlights: ... Credibility of content, quality of writing = 93% excellent or good ...

Perianal dermatologic exams are looking up

By Warren R. Heymann, MD Nov. 14, 2016 Every dermatologist confronts how to ask a person to disrobe for a full body skin examination. Ultimately, I came up with the following line when asked what should be exposed: "The more of you I see, the better off you are —

This month's news from across the specialty

What's hot ... April 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate ... Mallory Abate, MD Differentiating BCCs from intradermal nevi (IDN) along the lower eyelid margin can be tricky, but is important

July 24

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... Wound care after dermatologic procedures lacks uniformity In a recently published study in ... Dermatologic Surgery , investigators performed an assessment of postoperative dermatology handouts that shows high variability in patient instructions for wound care.

Here’s looking at you, KID

By Warren R. Heymann, MD April 7, 2017 Late skin findings in lethal keratitis-ichthyosis-deafness syndrome. Intertriginous hyperkeratosis and denudation in a patient with GJB2 p.A88V mutation. ... Credit: ... JAAD Keratitis, ichthyosis, and deafness (KID) syndrome is a rare genodermatosis associated with mutations in the GJB2 gene, which encodes connexin

PDF of AADA support letter

Honorable Lisa Murkowski The Honorable Tom Udall Chairman Ranking Member Subcommittee on Interior

IA25 Meeting Suites Guidelines

charge to be billed directly through Freeman: • exterior graphic panel to the right of the door • Interior

2025 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) exterior graphic panel to the right of the door • Interior

2026 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) Exterior graphic panel to the right of the door • Interior

AAD Event Advertising: Annual Meeting

The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities

PDF of Nominating Committee Member Rep. Regional Map

the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA

PDF of Board of Directors Regional Map

NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...

2025 AAD Innovation Academy Attendee Statistics

Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

2024 AAD Innovation Academy | Official exhibitor suppliers

Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA

Medical research funding

Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top

Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.

Council on Member Services AR 84 – 105 1. Recommendation for Action – October 6, 2022 a.

Becoming pro-geriatric by understanding progeria

By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive

Advocacy Update Feb. 4 2025

IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC

Advocacy Update Dec 9, 2025

IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,

Taking the challenge: Social media, adolescents, and the skin

By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the

PS-Joint Position Statement on Buffered Lidocaine

If a PEC is used, all interior surfaces of the PEC should be cleaned and disinfected at the beginning

Advocacy Update Feb. 18 2025

IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to

Advocacy Update Mar. 18, 2025

IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key

Annual Meeting Registration Comparison Statistics

Physician 1,468 1,513 1385 1464 1435 Non DCT Nurse (RN/LPN) 15 21 20 20 27 Non DCT Physician Assistant 84

Surviving and thriving after a natural disaster

Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us

Unrestricted fascination with restrictive dermopathy

By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and

PDF of position statement on medical spa standards of practice

reimbursed directly by public and private insurance. 27 28 Whereas, according to four nationwide surveys, 84%

PDF of resolutions opposing PA independent practice

reimbursed directly by public and private insurance. 27 28 Whereas, according to four nationwide surveys, 84%

April 7, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 7, 2021 ... Applying 2021 E/M coding concepts in everyday practice – Part 2 DermWorld Insights and Inquiries : Keeping an eye on melanoma AAD collaborates with OM1 to enhance

AAD Annual Meeting Registration Statistics Comparison

1,468 1,513 1435 1339 Non DCT Nurse (RN/LPN) 15 21 20 27 (new for AM16) Non DCT Physician Assistant 93 84

Primary sclerosing cholangitis associated with pyostomatitis vegetans and pyodermatitis vegetans: A potentially bilious situation

By Warren R. Heymann, MD Aug. 29, 2016 Inflammatory bowel disease may be associated with multiple cutaneous manifestations including pyoderma gangrenosum (PG), erythema nodosum, or directly by fistulae or "metastatic" Crohn disease. Seven cases of pyostomatitis vegetans-pyodermatitis vegetans (PSV-PDV) were reviewed. All 7 patients had inflammatory bowel disease (IBD) —

I’ll have a necrobiotic xanthogranuloma to go – with mustard!

By Warren R. Heymann, MD May 11, 2016 Mechlorethamine has been used for decades to treat cutaneous T cell lymphoma. Rodriguez et al utilized 0.01% topical nitrogen mustard to treat a 60+ year-old man with biopsy-proven NXG with paraproteinemia (IgG-κ), without myeloma. He had 20% body surface area involvement, including

PDF of Histiocytosis

Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW.

Glucose monitors: Not as sweet as they seem

By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial

A summary of current known risks for health care personnel treating COVID-19

highest in persons aged ≥85, ranging from 10% to 27%, followed by 3% to 11% among persons aged 65–84

PDF of small and large practice Academy MIPS guidance

INCENTIVE (42 points) (46 – 84 POINTS) 6 PI measures from each of the 4 objectives for all eligible

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was

This month's news from across the specialty

What's hot ... March 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS The American Journal of Public Health published a series of analyses on wasteful spending in United States health

You like tomato, I like tomahto, you soak with steroids, I use them dry…

By Warren R. Heymann, MD July 28, 2016 I have been a firm believer in the “Soak and Smear” approach to treating recalcitrant dermatoses, including atopic dermatitis, as detailed by Gutman et al, more than a decade ago. The authors defined soaking and smearing as soaking an affected body part

Advocating on behalf of dermatology is an enduring obligation

From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, December 1, 2019 The year is winding down, and as usual I find myself reminiscing about the last 12 months — thinking about all of the patients I

PDF of small and large practice guidance

each of the 4 INCENTIVE: objectives for all eligible encounters between Jan 1 – Dec 31, 2021: (61– 84

PDF of AADA letter in support of MA H1862 team based care

According to four nationwide surveys, 84% of respondents prefer a physician to have primary responsibility

PDF of MIPS guidance for large practices

(46 – 84 POINTS) 6 PI measures from each of the 4 objectives for all eligible * Note, the higher

Rapalogs for vascular lesions: Caveat mTOR

By Warren R. Heymann, MD Sept. 21, 2016 Rapalogs are drugs that inhibit the mTOR pathway and include sirolimus (rapamycin), temsirolimus, everolimus, and deforolimus. All are immunosuppressive and have antineoplastic/antiproliferative effects. The mTOR protein is a serine-threonine kinase involved in complex intracellular signaling pathways affecting the key processes of cell

2020 Legislative Conference Overview of Asks

Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.

Key messages to communicate about Indoor tanning

Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger

Nov. 6, 2021 AAD/AADA Board Agenda

Presidential Citation Awards SUPP 84-89 Page 1 of 8 TIME

PDF of optimizing the genital exam

has a variety Having an organized approach helps ensure that noth- Dermatol, 2020. 82 (6): pp. 1277-84

PDF of Reporting Options Large Practices

** INCENTIVE: Additional bonus measure available for e-Prescribing If applicable, CMS will (61– 84

PDF of MIPS guidance for small practices

INCENTIVE 42 points (46 – 84 POINTS) 3 quality measures that can achieve a maximum of 1 high-weighted

February 21

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / FEBRUARY 21, 2018 ... CMS releases MIPS quality performance scores Vote in the AAD election by March 3 Study indicates e-consults improve access to dermatology How helpful is federal research funding?

Melanoma Reporting — Measure 397

Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process

2024 AAD Annual Meeting Sponsorship Prospectus

sponsorships are also available for the 2024 AAD Innovation Academy (formerly Summer Meeting) in Seattle, WA

AMA introduces new prolonged service code for 2021

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding and reimbursement, January 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . Coding based on time ... As previously discussed

PDF of the Academy's letter opposing FL HB 607

According to four nationwide surveys, 84% of respondents prefer a physician to have primary responsibility

This month’s news from across the specialty

What’s hot ... December 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD More than 80% of prior authorization appeals are overturned. Insurance plans’ most common interventions to manage utilization

Old stains leaving new marks in dermatology

... By Warren R. Heymann, MD Oct. 15, 2018 A new blue-gray papule was noted on the left side of the neck and was excised as outlined by gentian violet surgical marker. ... Credit: ... JAAD Periodically I will pull an ancient tie from my rack. I’m delighted if

Diagnosing infectious diseases in 2028: Let the good times roll

By Warren R. Heymann, MD Aug. 27, 2018 You may be overwhelmed by the "omics" — genomics, epigenomics, transcriptomics, proteomics, metabolomics, with good reason. "Big Data" are changing the diagnostic landscape in infectious diseases and oncology at breakneck speed. Warning: By the time this is posted, it may be obsolete!

Understanding the risk of Wilms Tumor in hemihypertrophy: Are we halfway there?

By Warren R. Heymann, MD Nov. 16, 2017 ... Diffuse capillary malformation with overgrowth. A 2-month-old girl with ill-defined erythematous patches of the bilateral upper extremities, posterior trunk, and left lower extremity. There is also overgrowth of the left lower extremity. ... Credit: ... JAAD Wilms tumor (WT, nephroblastoma) is

Viva ex vivo dermoscopy?

By Warren R. Heymann, MD March 12, 2017 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope. ... Credit: ... JAAD It has been said that the best "special stain" is a deeper section — wise words indeed. While always gratifying

April 20, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 20, 2022 ... Which biologics are most effective for psoriasis? DermWorld Insights and Inquiries : One Toker over the line — Clarifying Toker cell hyperplasia in Zuska disease and its

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type

Biotin supplementation for hair and nail health: Does it pass the test?

By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,

After 23 years, a syndrome converted me into an eflornithine believer

By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.

This month's news from across the specialty

What's hot ... October 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD We all know how frustrating it can be when a patient’s acne returns after isotretinoin, requiring them to undergo

Obituaries

Obituaries ... By Jerry Graff, MD, June 3, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JON GARRY BEIDLER, MD, of Chambersburg, Pennsylvania, Dec. 30, 2018, at age 82. Trained in dermatology at University of Pennsylvania and practiced in

This month’s news from across the specialty

What’s hot ... February 1, 2025 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD The Nation’s Health by the American Public Health Association published a ... special report on improving health

Untangling the neurologic comorbidities of bullous pemphigoid

By Warren R. Heymann, MD June 6, 2017 Response of a patient with bullous pemphigoid (BP) after 6 omalizumab injections as monotherapy. A, Involvement of the back of a steroid-refractory patient with BP before omalizumab treatment. B, Four months after beginning omalizumab as monotherapy, the inflammatory plaques have largely resolved,

December 18, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 18, 2024 ... Combined topical 5-FU and calcipotriene for superficial keratinocyte carcinomas DermWorld Insights and Inquiries : Holiday greeting 2025 FDA approves tapinarof cream for atopic dermatitis Upadacitinib vs. dupilumab

January 24

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / JANUARY 24, 2018 ... Psoriasis treatments: Which ones are the most effective? AAD names Dirk Elston, MD, next JAAD editor SCC death reports may be inaccurate Does adherence vary by treatment?

AR - Procedures for Proposed Amendments to the Articles of Incorporation and Bylaws

Owner: Executive Reviewed: 5/15/2021 Approved: Board of Directors \226 6/21/84 Revised: Board of

PDF of MIPS Reporting Options for Small Practices

each of the 4 INCENTIVE: objectives for all eligible encounters between Jan 1 – Dec 31, 2021: (61– 84

This month’s news from across the specialty

What’s hot ... March 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD New, but not new, but maybe new, but not good = ... Candida auris is looking worse with

May 7, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 7, 2025 ... Low-dose oral minoxidil vs. combination therapy with dutasteride or finasteride DermWorld Insights and Inquiries : Getting a head up on cutaneous scalp malignancies Academy mourns the passing

DermWorld physician editor search

The American Academy of Dermatology’s award-winning monthly magazine, ... DermWorld , seeks candidates to serve as its next paid physician editor. ... Position overview ... The Physician Editor is appointed for an initial four-year term beginning Jan. 1, 2026, which may be renewed for a second four-year term with the

Selecting an EHR

If you are part of a paper-based practice that has not adopted an electronic health record (EHR), it is time to adopt one. CMS has made it difficult to participate in the ... Merit-based Incentive Payment System (MIPS) program without an EHR. ... Dermatologists can still report quality data through

Tarrying for tapinarof

By Warren R. Heymann, MD, FAAD January 12, 2022 Vol. 4, No. 2 Today we held our first round of interviews for our dermatology residency program for 2023. Meeting dermatology resident applicants is a delight — they are brilliant, engaging, and a source of pride for our discipline. We started

MIPS 2020 is here. Here are the highlights

Answers in Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, April 1, 2020 Each month Dermatology World ... tackles issues "in practice" for dermatologists. This month Faiza Wasif,

This month’s news from across the specialty

What’s hot ... June 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Christen Mowad, MD, FAAD The American Academy of Dermatology SPOT Skin Cancer™ program has been very well received and provides a community service

This month’s news from across the specialty

What’s hot ... March 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many

April 28, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?

December 18, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 18, 2019 ... Which physicians were sued most in 2019? DW Insights and Inquiries: Holiday greeting 2020 — eyeing dermatology’s future New DW Academy Insider coming in 2020 Does teledermatology

March 27, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 27, 2024 ... Spironolactone: Risk of breast, gynecologic malignancies? DermWorld Insights and Inquiries : Always another worry for patients with hidradenitis suppurativa — Amyloid A amyloidosis FDA approves spesolimab for

May 11, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants

October 2, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 2, 2019 ... Does gluten increase risk for psoriasis and AD in women? DW Insights and Inquiries : Cutting giant congenital nevi down to size molecularly Upcoming coding changes: Differentiating

March 20, 2023 AAD/A Board of Directors agenda

Resort & Spa, Itasca, IL 2024 Innovation Academy – August 1-4, 2024 (Thurs – Sun) Seattle, WA

Agenda of the July 23, 2022 AAD/A Board of Directors meeting.

600 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA

Summary of MIPS 2021 changes

Answers in Practice ... By Faiza Wasif, MPH, manager, practice management, February 1, 2021 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Faiza Wasif, MPH, the Academy’s Practice Management manager, offers a summary of MIPS changes in 2021. CMS released the final Quality Payment Program (QPP)

This month's news from across the specialty

What's hot ... October 1, 2020 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... ED COWEN, MD Why do a small percentage of young and apparently healthy patients with COVID-19 develop life-threatening infection or a Kawasaki syndrome-like

Oy, another “Oid” to worry about: Cryptococcoid lesions

By Warren R. Heymann, MD July 3, 2019 Vol. 1, No. 17 The suffix "oid" m ... eans "resembling." There is a plethora of "oids" in dermatology — lichenoid, Pagetoid, rupioid, targetoid, to name a few. (My favorite is "oid-oid" disease, aka Sulzberger-Garbe disease, or exudative discoid and lichenoid chronic

A future therapeutic Harlequin Romance?

By Warren R. Heymann, MD Sept. 17, 2018 A neonate with harlequin ichthyosis on day 21 of life after 3 weeks of treatment with acitretin at 1 mg/kg/d. ... Credit: ... JAAD My fiancé Ronnie, then a pediatric resident, called me excitedly, asking for my opinion about a remarkable neonate

May 5, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 5, 2021 ... Is dutasteride an effective treatment for frontal fibrosing alopecia? DermWorld Insights and Inquiries : Digging deeper into lupus erythematosus panniculitis Which herbal supplements may affect autoimmune skin

COVID-19 dermatology registry

Thank you for agreeing to take part in this important effort on behalf of the American Academy of Dermatology and the International League of Dermatologic Societies. Our hope is that information you and others provide will help us understand dermatologic manifestations of the COVID-19 virus, as well as skin reactions

A tug of war

The AADA continues to make headway against scope of practice threats. ... Feature ... By Allison Evans, Assistant Managing Editor, September 1, 2024 The tug of war for scope expansion continues. As both sides are poised to pull the rope — and with it the opposing team — across the

This month’s news from across the specialty

What’s hot ... December 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Harry Dao Jr., MD, FAAD One advantage of working in the same practice as your surgeons is the ability to quickly confirm biopsy

Diagnosing the primary cutaneous SMARCA4-deficient cutaneous tumor: You don’t know what you got ‘til it’s gone

By Warren R. Heymann, MD, FAAD Nov. 5, 2025 Vol. 7, No. 44 Understandably, dermatologists are often surprised to receive a histopathologic diagnosis of Merkel cell carcinoma, given the relatively nondescript clinical features that suggest a basal cell carcinoma or inflamed cyst. The purpose of this commentary is to introduce

August 1

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / AUGUST 1, 2018 ... Physicians suing patients over negative reviews FDA to laser device manufacturers: Stop marketing for vaginal rejuvenation FDA releases biosimilars plan to increase access, encourage competition Blood test

September 29, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 29, 2021 ... Is HPV vaccination associated with clearance of common warts? DermWorld Insights and Inquiries : Positively perplexing — Determining the meaning of CD30 positivity FDA proposes new guidance

The nexus of VEXAS syndrome

By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS

PDF of member ethics resources

J Am Acad Dermatol. 2021 Feb;84(2):585. doi: 10.1016/j.jaad.2020.09.080. Epub 2020 Oct 1.

Professionalism and Ethics

Ethics and medicine have been intertwined since the dawn of our profession. From the ancient Hippocratic Oath to the principle of ... primum non nocere to modern-day principlism, medical ethics have evolved over time. ... As public and professional interest in medical ethics increases, it is important for clinicians, researchers,

AAD Innovation Academy 2020 Technical Exhibitor Prospectus

Friday. 70 Pike St., Seattle, WA 98101 Welcome Reception (Exhibits Open) 3 Thursday, August 13 ......

PDF of AAD Atopic Dermatitis pediatric comorbid conditions guideline draft

Allergol Immunopathol 721 (Madr) 2023;51:101-9. 722 84.

PDF of joint comments oppose TX Rule 193.17

to dermal fillers, a survey conducted by the Physicians Coalition for Injectable Safety found that 84

Getting a head up on cutaneous scalp malignancies

By Warren R. Heymann, MD, FAAD May 7, 2025 Vol. 7, No. 18 I’m confident that your alopecic patients with a suspected keratinocyte carcinoma or melanoma of the scalp jokingly ask you to be careful with your biopsy procedure so they do not lose any more hair. While patients and

Time to reassess messing around with steroids and psoriasis

By Warren R. Heymann, MD March 3, 2021 Vol. 3, No. 9 You don't tug on Superman ’ ... s cape You don't spit into the wind You don't pull the mask off that old Lone Ranger And you don't mess around with Jim If the late Jim Croce was

Getting steamed over vaping

By Danielle DeHoratius, MD January 29, 2020 Vol. 2, No. 4 Danielle DeHoratius, MD ... To call vaping an epidemic is an understatement. As of Oct. 15, 2019, the CDC has confirmed 33 deaths among the 1,479 lung injuries associated with the use of e-cigarettes (1). Every state but Alaska

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months

PDF of AK guideline for comment

Development, and Evaluation 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84

Minutes of the AAD's March 21, 2021 Annual Business Meeting.

. 79 Bristol-Myers Squibb 80 Dermstore 81 Janssen Biotech, Inc. 82 LEO Pharma Inc 83 Novartis 84

Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid

By Warren R. Heymann, MD Oct. 7, 2020 Vol. 2, No. 40 It is not my imagination — I have been seeing more cases of bullous pemphigoid (BP) than ever. This is likely a function of an aging population in concert with an increase of drug-induced cases, notably with dipeptidyl

The profound dermatological manifestations of COVID-19: Part VII — Who was that masked man?

By Warren R. Heymann, MD Sept. 23, 2020 Vol. 2, No. 38 Disclaimers: This commentary was written on Sept. 12, 2020 for a publication date of Sept. 23, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual

Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis

By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and

Reassuring patients with sclerosing lymphangitis of the penis that they will not get shafted

By Warren R. Heymann, MD, FAAD July 17, 2024 Vol. 6, No. 29 Over the past decade of using our electronic medical record, I must have clicked on the word "reassurance" thousands of times for anxious patients with lesions of no biological concern. Today you will calm patients who are

Trichobacteriosis: A salute to the Shelleys

By Warren R. Heymann, MD, FAAD Sept. 3, 2025 Vol. 7, No. 35 Indelible memories form in youth. I couldn’t wait to get my New York driver’s license — within a year of that milestone the 1973 oil embargo hit, and most drives were limited to the gas station to

Eosinophilic dermatosis of hematologic malignancy: Reality bites

By Warren R. Heymann, MD July 24, 2019 Vol. 1, No. 20 Our new gazebo’s screening beckons! Finally completed late last fall, I have longingly stared at it, waiting for spring’s warm embrace to invite me in. I cherish being outside, but in the shade and protected from the annoyance

January 26, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 26, 2022 ... Allergens in hand sanitizers DermWorld Insights and Inquiries : Eccrine syringofibroadenoma — Sweating over the details Derm Coding Consult : Applying 2021 E/M coding concepts in everyday

PDF of proposed guidelines on AD and phototherapy

data. 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84

PS-Climate and Health

Int J Womens Dermatol 2021;7\(1\:70-84. doi:10.1016/j.ijwd.2020.08.007 13.

PDF of 2020 MIPS reporting snapshot

icaroints. e participating provider0.5%), . you must SMALL SMALL score bIINCENTIVE NCENTIVE etween 46 and 84

PDF of Academy's opposition to LA SB 166

According to four nationwide surveys, 84% of respondents prefer a physician to have primary responsibility

Draft minutes of the March 27, 2022 AAD Annual Business Meeting.

Brodell, MD, FAAD 82 83 For Vice-President Elect 84 Cyndi J.

Coming clean on chlorhexidine-induced dermatoses

By Warren R. Heymann, MD, FAAD March 13, 2024 Vol. 6, No. 11 Dermatologic surgeons use a variety of products that may cause an irritant or allergic contact dermatitis, including antiseptics, anesthetics, gloves, suture materials, tissue adhesives, topical antibiotics, and bandages. Antiseptic agents are the most frequent cause of contact

Juvenile lichen sclerosus: A loss of innocence

By Warren R. Heymann, MD August 19, 2020 Vol. 2, No. 33 Juvenile lichen sclerosus (LS) is a difficult disorder — symptomatically, emotionally, diagnostically, and therapeutically. During my residency it was "common knowledge" that juvenile LS would abate by adolescence. I am always curious how such perceptions become dogma, only

Reflections on reflectance confocal microscopy for diagnosing benign lichenoid keratoses

By Warren R. Heymann, MD, FAAD July 5, 2023 Vol. 5, No. 27 At the inception of my dermatology residency in July 1980 I read a brief article entitled "Benign Lichenoid Keratosis" (BLK) by Detlef Goette (1) and thought to myself "Remember this — I’ll probably see this lesion now

The malignant risk in circumscribed palmar or plantar hypokeratosis: Summoning Charles Dickens and Freddie Mercury

By Warren R. Heymann, MD, FAAD May 14, 2025 Vol. 7, No. 19 Smitten by the seminal article in 2002 by Pérez et al. describing circumscribed palmar or plantar hypokeratosis (CPPH), I have diagnosed the disorder several times, reassuring patients that this oddity is of no concern. More than 100

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with

PDF of Dermatologic adverse events

have been reported -For grade 2 events and higher, immu- ADL Taylor Gray, seen 10-30% of the time 3-84

A slippery slope

Non-physician providers seek authority to perform cosmetic medical procedures, threatening patient safety and the value of specialty medical training ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2022 The Academy has been monitoring and responding to a variety of proposals and bills in the aesthetic arena that

Battling scope expansions in Colorado

Ask the Expert ... By Victoria Houghton, Managing Editor, June 1, 2022 DermWorld spoke to Geoffrey Lim, MD, FAAD, legislative trustee for the Colorado Dermatologic Society Executive Board, about its efforts with the American Academy of Dermatology Association (AADA) to advocate against state scope of practice expansions. DermWorld: In a

Progress in pemphigus: Solidifying rituximab’s role

By Warren R. Heymann, MD, FAAD July 7, 2021 Vol. 3, No. 27 "Now what do I do?" ... That question, asked by dermatologists every day about patients who are not responding to therapy, was posed in the preface of the first (and every subsequent) edition of ... Treatment of

Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?

By Warren R. Heymann, MD, FAAD December 8, 2021 Vol. 3, No. 48 Ask any dermatology resident what the first-line treatment is for infantile hemangiomas (IH) and you will get a matter-of-fact response — "propranolol" — as if this has been an entrenched fact for decades. Barely more than a

Dermatologic ergonomics: Straighten up and fly right

By Warren R. Heymann, MD, FAAD June 28, 2023 Vol. 5, No. 26 My posture has never been proper, having a proclivity to slouch. "Stand up straight, son!" my father would admonish. When I was young and supple, I would half-listen to the advice, usually reverting to my standard (incorrect)

PDF of Academy advocacy scope letter 01.15.20

According to four nationwide surveys, 84% of respondents prefer a physician to have primary responsibility

Keeping abreast of drug-induced cutaneous lupus

By Warren R. Heymann, MD, FAAD Aug. 4, 2021 Vol. 3, No. 31 Tom Hanks, as Commander Jim Lovell in the movie ... Apollo 13, lamented that the world was not watching their onboard video, compared to Neil Armstrong’s moon landing a year earlier. Reality dictates that the seminal breakthroughs

Here comes summer (and sunscreen conversations)!

By Warren R. Heymann, MD April 29, 2020 Vol. 2, No. 17 As the summer solstice approaches, days will lengthen, as will patient-related conversations regarding sunscreen use. In this anxiety-ridden age, with all the information overload, patients’ questions have expanded beyond what sunscreen we recommend. Concerns for safety — both

Eye-opening news about oxymetazoline

By Warren R. Heymann, MD, FAAD April 27, 2022 Vol. 4, No. 17 Certain articles have a "wow" factor that immediately impacts practice. In 2007, I recall being impressed by the 2 cases of erythematotelangiectatic rosacea reported by Shanler and Ondo that dramatically improved with the application of oxymetazoline hydrochloride

The naked truth about total body skin examination: A lesson from Goldilocks and the Three Bears

By Lorraine L. Rosamilia, MD Nov. 13, 2019 Vol. 1, No. 36 In my last 13 years of immersion in dermatology, I have often asked this simple yet elusive question of my superiors, my colleagues, and myself: Which patients need skin checks? As I peruse my clinical schedule, in which

Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and Carteaud

By Warren R. Heymann, MD, FAAD Feb. 5, 2025 Vol. 7, No. 5 Congratulations to Aaron Judge for setting the American League seasonal record in 2023 for the most home runs — 62 — a remarkable feat. I was only six years old when Roger Maris* slammed his 61st home

PDF of BF transplant dermatology

Basal cell carcinoma 10-fold 3 Melanoma 3.4-fold 2 Merkel cell carcinoma 24.6-fold 2 Kaposi sarcoma 84

Running dry

Identifying the steps needed to ease the looming physician workforce shortage ... Feature ... By Ruth Carol, Contributing Writer, December 1, 2021 For years, there has been concern that a physician workforce shortage is looming. The United States could see a shortfall of 37,800 to 124,000 physicians by 2034, according

Always another worry for patients with hidradenitis suppurativa: Amyloid A amyloidosis

By Warren R. Heymann, MD, FAAD March 27, 2024 Vol. 6, No. 13 My introduction to hidradenitis suppurativa (HS) was as a first-year dermatology resident on the inpatient dermatology service at Van Etten Hospital in the Bronx, caring for a most unfortunate woman with HS; she had secondarily infected pyoderma

Seeing red with dupilumab

By Warren R. Heymann, MD, FAAD March 1, 2023 Vol. 5, No. 9 Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other eczematous disorders, bullous pemphigoid, Kimura disease, etc. when used

The expanding horizon of anti-IL-36 therapy

By Warren R. Heymann, MD, FAAD Sept. 25, 2024 Vol. 6, No. 39 An abridged version of this commentary was published in "A Clinician’s Perspective" in the April 2024 issue of the JAAD ... . We last explored the relationship between IL-36 and generalized pustular psoriasis (GPP) and the use

A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis

By Warren R. Heymann, MD, FAAD Feb. 1, 2023 Vol. 5, No. 5 It only takes a nanosecond for a dermatologist to recognize the "salt and pepper" dyspigmentation (SPD) of systemic sclerosis (SSc), but a lifetime to understand and manage it. Of all the cutaneous signs of SSc (sclerodactyly, telangiectasias,

Previous AAD Annual Meeting registration statistics

1,468 1,513 1435 1339 Non DCT Nurse (RN/LPN) 15 21 20 27 (new for AM16) Non DCT Physician Assistant 93 84

Your Dermatologist Knows

An update on the Academy’s successful consumer positioning strategy. ... Feature ... By Matt Walsh, Specialist, Member Communications, December 1, 2025 2026 will be the fourth full year of the Academy’s revolutionary push to position board-certified dermatologists as the experts in skin, hair, and nail health. Since launching in October

Deeper thoughts about acne keloidalis nuchae

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, February 1, 2026 Vol. 8, No. 2 Wallace Clark taught me the truism that thinking often ceases when a diagnosis is rendered. The clinical diagnosis of acne keloidalis nuchae (AKN) is straightforward. Embarrassingly, I had not given much thought

Metformin mania: Is it an adequate chemopreventive agent for skin cancer?

By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now

Caveat mTOR revisited: Neurofibromatosis

By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their

PDF of AAD Atopic Dermatitis pediatric supplement draft

J Allergy Clin Immunol 2002;110:277-84. 6. NCT00828412.

PDF of AAD Atopic Dermatitis diagnostic testing supplement draft

months 24 months 8 months (Dupi) 240 months NR 4 months (Dupi) “several years” NR 27 months (Dupi) 84

A ioint ACR, AAD, RDS, and AAO statement on hydroxychloroquine use with respect to retinal toxicity

Arthritis & rheumatology. 2015;67(8):2176-84. 11. Melles RB, Marmor MF.

Hard questions about subcutaneous fat necrosis of the newborn and hypercalcemia

By Warren R. Heymann, MD, FAAD May 8, 2024 Vol. 6, No. 19 Neonatal dermatoses are anxiety-provoking for both physicians and parents because of crucial questions — Are there associated systemic problems? What are long-term sequelae? How should the infant be followed? One of the most striking neonatal disorders is

A checkup on immune checkpoint inhibitor-induced subacute cutaneous lupus

By Warren R. Heymann, MD, FAAD March 15, 2023 Vol. 5, No. 11 Keeping up with the expanding indications and adverse reactions to immune checkpoint inhibitors (ICIs) can be a full-time job. These drugs are anti-neoplastic because of cytotoxic T-cell activation. ICIs include the anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) agent ipilimumab,

PDF of draft atopic dermatitis comorbidities guideline

available data at the time the guideline 2 AAD Draft AD Comorbidity Guidelines th July 6 , 2021 84

Pathway to reducing medical errors

By Jason B. Lee, MD, FAAD June 26, 2024 Vol. 6, No. 26 The 2000 landmark report by the Institute of Medicine ... To Err Is Human: Building a Safer Health System ushered in the patient safety movement in the modern era. (1) The report highlighted nearly 98,000 hospital deaths

The profound dermatological manifestations of COVID-19: Part V – Pediatric multisystem inflammatory syndrome

By Warren R. Heymann, MD May 13, 2020 Vol. 2, No. 19 Disclaimers: This commentary was written on May 7, 2020 for a publication date of May 13, 2020. The issues related to the COVID-19 pandemic are changing by the millisecond. The content included in this commentary may no longer

PDF of AD guidelines on phototherapy supplement

estimate; the true effect is likely to be substantially different from the estimate of effect. 83 84

The email ballot for the Nov. 6, 2021 AAD and AADA Board of Directors meetings.

Page 84 - AADA Board of Director Minutes August 7, 2021 - Motion to approve the AADA Board of Directors

Supplement of AK guideline for comment

20Practice%20Guidelines.pdf 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84

Keeping pace

Life-changing advances and a multidisciplinary approach give new hope to patients with Merkel cell carcinoma ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2021 When Paul Nghiem, MD, PhD, FAAD, first started treating patients with skin cancer almost 20 years ago, physicians had little understanding of how

Pediatric diseases in disguise

Dermatologists discuss conditions that may be harder to diagnose in children. ... Feature ... By Allison Evans, Assistant Managing Editor, October 1, 2025 Despite years of rigorous training and experience, even the best dermatologists may miss a pediatric diagnosis, particularly for dermatologists who don’t see as many pediatric patients. Some

Managing menopause

Dermatologists discuss dermatologic changes before and during menopause and the dermatoses that may occur. ... Feature ... By Allison Evans, Assistant Managing Editor, December 1, 2025 Menopausal transitions can be stressful. While rapidly declining estrogen levels can wreak havoc internally, many of these changes involve the skin, hair, and vulvar

From Down Under to all over: Kava-induced cutaneous adverse reactions

By Warren R. Heymann, MD, FAAD June 11, 2025 Vol. 7, No. 23 Firmly ensconced in my bucket-list travel time, I eagerly anticipate our trip to New Zealand, Tasmania, and mainland Australia in January 2025. ... (Editor’s note: This piece was written prior to the trip.) As a dermatologist, I

PDF of AAD Atopic Dermatitis pediatric guideline draft

this 71 guideline to reflect new data. 72 73 74 75 76 77 78 79 80 81 82 83 84

PDF of scope of practice toolkit

According to four nationwide surveys, 84% of respondents prefer a physician to have primary responsibility

COVID-19 and dermatology

What have we learned about the cutaneous manifestations of the virus and the vaccines? ... Feature ... By Emily Margosian, Assistant Editor, December 1, 2021 While the immediate and long-term effects of COVID-19 on the human body are still being studied, new research regarding the cutaneous manifestations of the virus

Sky high

PBM tactics increase drug prices, lower patient access ... Feature ... By Ruth Carol, Contributing Writer, September 1, 2022 Last month, ... DermWorld discussed the role pharmacy benefits managers (PBMs) play in the drug distribution chain. This month, we will discuss some of the tactics PBMs use that are driving

Embracing change

Go to AAD Home ... Go to AAD Home ... Menu ... Strategies to help dermatologists adapt – and be happy about it ... Strategies to help dermatologists adapt – and be happy about it ... By Ruth Carol, contributing writer It seems as if a day doesn’t go by

The not-so-full body skin examination

By Warren R. Heymann, MD, FAAD April 16, 2025 Vol. 7, No. 15 It is not my imagination. With every passing year, an increasing number of new patients schedule an appointment for a full (or total) body skin examination (FBSE, TBSE) to be checked (or, as some patients say, "scanned")

Search

Filters

Content Filters

Content Type